Eight Israeli startups were named to the third annual Digital Health 150, an annual global ranking by New York-based research firm CB Insights of the 150 most promising companies using digital technology to transform the healthcare industry.
CB Insights provides a tech market intelligence platform that analyzes data on private companies, venture capital, partnerships, and investor activities. This year’s Digital Health 150 was unveiled live during CB Insights’ annual Future of Health event.
1. DiA Imaging Analysis
Israel’s DiA Imaging Analysis is a leading provider of advanced AI-based solutions for ultrasound analysis. The company’s software enables users to identify clinical indications and abnormalities accurately. The company’s LVivo product line for cardiac and abdominal automated analysis allows clinicians with various levels of ultrasound experience to use and analyze ultrasound images on their ultrasound devices or healthcare IT systems with increased speed, efficiency, and accuracy.
The Israeli medical imaging startup, which has offices in Ramat Gan and Beersheba in Israel and Connecticut in the US, was founded in 2009 by Hila Goldman-Aslan (CEO), Michal Yaacobi, Arnon Toussia-Cohen, and Dr. Noah Liel-Cohen. According to CB Insights, the company has raised at least $19 million to date from companies that include Connecticut Innovations, XTX Ventures, Downing Ventures, DEFTA Partners, and Philips.
The Tel Aviv-based mobile health platform Sweetch increases patient adherence across various aspects of disease management and improves clinical outcomes for people with chronic conditions. Sweetch says it is the first to combine AI and EI (emotional intelligence) to learn patients’ real-life behavior patterns and optimize engagement
Founded in 2013, one of the company’s offerings is an AI-based platform that seeks to identify those at high risk of developing Type 2 diabetes.
Lumen is a handheld, portable device to accurately measure metabolism. The company uses a CO2 sensor and flow meter to determine the CO2 concentration in a single breath, in less than a minute, which was previously only possible through an hour-long lab test. This indicates the type of fuel your body is using to produce energy. Lumen also includes an application that acts as a virtual nutritionist, providing dietary and exercise recommendations based on the user’s metabolism.
The Tel Aviv-based startup was founded as Metaflow in 2014 by Daniel Tal, Dror Ceder, and Avi Smila, the founders of social toolbar app developer Wibiya and twin sisters Michal and Merav Mor, athletes who compete together in Ironman competitions and ultra-marathons.
Israeli-founded surgical firm Theator works to leverage advanced AI and computer vision tech to improve the performance of a surgeon. It provides video analytics to enable surgeons to review and assess their work from pre-op preparation to post-op analysis at different angles.
5. Nym Health
Founded in 2018 by Amihai Neiderman and Adam Rimon, Nym Heath develops coding software that allows clinical data to be processed autonomously, efficiently, and accurately, the company says.
Deployed in more than 40 hospitals across the United States, Nym is reinventing medical coding for revenue cycle management (RCM). The Nym platform modernizes RCM using direct-to-billing, fully autonomous medical coding that reduces insurance denials and operational expenses, accelerates payment cycles, and maximizes audit readiness for healthcare providers.
Empathy is an Israeli-founded startup that provides a new financial technology application and emotional guide that aims to address the set of opposite needs that fall upon the bereaved, including managing a maze of bureaucracy and coping emotionally with the pain of loss. The company launched in April with $13 of seed funding and raised $30 million in October for a total of $43 million to date.
7. Vocalis Health
Israeli-founded startup Vocalis Health is a company pioneering AI-based voice biomarkers in healthcare. Founded in 2019 in the merger of two early-stage Israeli AI healthtech firms Beyond Verbal and Healthymize, the company’s products are cleared by the US Food and Drug Administration (FDA.)
Earlier this year, the company’s COVID-19 screening tool, VocalisCheck, received a CE mark, becoming the first device to receive CE mark approval for the medically intended use of screening for COVID-19.
C2i Genomics offers post-surgery monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
C2i’s liquid biopsy is a tool for cancer tumor monitoring. It works by identifying subtle changes in genetic patterns across the entire tumor.
Founded in 2019 by Israelis Ezra Sofer, Asaf Zviran, and Boris Oklander, the startup has offices in New York and Massachusetts and an R&D center in Haifa.